Search for: "Akorn Pharmaceuticals Inc."
Results 1 - 18
of 18
Sorted by Relevance
|
Sort by Date
1 Mar 2019, 11:45 am
In Akorn, Inc. v. [read post]
22 Jul 2018, 8:32 pm
IPR2016-01127, IPR2016-01128, IPR2016-01129, IPR2016-01130, IPR2016-01131, and IPR2016-01132 (and parallel IPRs filed by Petitioners Teva Pharmaceuticals USA, Inc. and Akorn, Inc., which had... [read post]
9 Sep 2013, 9:27 pm
• Defendant: Akorn, Inc. [read post]
9 Oct 2018, 6:21 am
Akorn, Inc. v. [read post]
19 Jul 2015, 9:59 pm
Akorn Inc. 1:15-cv-00474; filed June 11, 2015 in the District Court of Delaware Infringement of U.S. [read post]
30 Sep 2019, 9:02 am
Akorn, Inc., No. 18-1418 (Whether no-opinion judgments comply with 35 U.S.C. [read post]
30 Nov 2016, 10:22 am
Defendant Akorn, Inc., a generic drugmaker based in Lake Forest, Illinois, filed an Abbreviated New Drug Application (“ANDA”) with the U.S. [read post]
23 Jul 2018, 2:38 pm
Mylan Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., AKORN, Inc. [read post]
20 Jul 2018, 11:44 pm
TevaPharmaceuticals USA, Inc., and Akorn, Inc. [read post]
15 May 2019, 9:24 am
Akorn, Inc., No. 18-1418 (Supreme Court 2019) with the following two questions: Whether 35 U.S.C. [read post]
24 Jan 2012, 6:34 pm
Akorn’s ANDA, which FDA has not yet tentatively approved, contains a Paragraph IV certification to the ‘269 patent; however, according to the court, non-party Teva Pharmaceuticals USA, Inc. [read post]
19 Oct 2017, 10:29 am
” Generic drug manufacturers Teva Pharmaceuticals USA, Inc.; Akorn, Inc.; Mylan, Inc.; and Mylan Pharmaceuticals, Inc., that wish to manufacture and sell bioequivalent drugs having the same components as Restasis challenged that the patents asserted by Allergan are invalid in defense to a patent infringement suit filed by Allergan. [read post]
19 Oct 2017, 10:29 am
” Generic drug manufacturers Teva Pharmaceuticals USA, Inc.; Akorn, Inc.; Mylan, Inc.; and Mylan Pharmaceuticals, Inc., that wish to manufacture and sell bioequivalent drugs having the same components as Restasis challenged that the patents asserted by Allergan are invalid in defense to a patent infringement suit filed by Allergan. [read post]
19 Jun 2019, 6:18 am
Teva Pharmaceuticals USA, Inc. [read post]
8 Oct 2019, 9:44 am
Akorn, Inc., No. 18-1418 (propriety of R.36 judgments; obviousness) Imperium IP Holdings (Cayman), Ltd. v. [read post]
12 Sep 2022, 8:35 am
Green Farms, Inc. [read post]
5 Apr 2012, 9:19 am
Finally last December Lundbeck sold its pentobarbital rights to Illinois-based Akorn Inc., which signed an agreement promising it would not sell the drug for the purpose of executions. [read post]
18 Jun 2019, 6:42 am
Aruba Networks, Inc., C.A. [read post]
